Atai Life Sciences Statistics Share Statistics Atai Life Sciences has 214.16M
shares outstanding. The number of shares has increased by 19.64%
in one year.
Shares Outstanding 214.16M Shares Change (YoY) 19.64% Shares Change (QoQ) 1.23% Owned by Institutions (%) 12.42% Shares Floating 136.72M Failed to Deliver (FTD) Shares 42 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 15.84M, so 7.47% of the outstanding
shares have been sold short.
Short Interest 15.84M Short % of Shares Out 7.47% Short % of Float 9.59% Short Ratio (days to cover) 1.84
Valuation Ratios The PE ratio is -1.43 and the forward
PE ratio is -9.98.
Atai Life Sciences's PEG ratio is
-0.01.
PE Ratio -1.43 Forward PE -9.98 PS Ratio 691.6 Forward PS 4567.3 PB Ratio 1.83 P/FCF Ratio -2.58 PEG Ratio -0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Atai Life Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.21,
with a Debt / Equity ratio of 0.21.
Current Ratio 3.21 Quick Ratio 3.21 Debt / Equity 0.21 Debt / EBITDA -0.17 Debt / FCF -0.3 Interest Coverage -32.87
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $5.7K Profits Per Employee $-2.76M Employee Count 54 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -356K Effective Tax Rate 0.24%
Stock Price Statistics The stock price has increased by 248.85% in the
last 52 weeks. The beta is 1.55, so Atai Life Sciences's
price volatility has been higher than the market average.
Beta 1.55 52-Week Price Change 248.85% 50-Day Moving Average 3.21 200-Day Moving Average 2.02 Relative Strength Index (RSI) 70.54 Average Volume (20 Days) 5,567,291
Income Statement In the last 12 months, Atai Life Sciences had revenue of 308K
and earned -149.27M
in profits. Earnings per share was -0.93.
Revenue 308K Gross Profit 308K Operating Income -102.69M Net Income -149.27M EBITDA -145.33M EBIT -145.28M Earnings Per Share (EPS) -0.93
Full Income Statement Balance Sheet The company has 17.5M in cash and 24.71M in
debt, giving a net cash position of -7.2M.
Cash & Cash Equivalents 17.5M Total Debt 24.71M Net Cash -7.2M Retained Earnings -700.21M Total Assets 189.2M Working Capital 77.13M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -82.44M
and capital expenditures -95K, giving a free cash flow of -82.53M.
Operating Cash Flow -82.44M Capital Expenditures -95K Free Cash Flow -82.53M FCF Per Share -0.52
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -33341.23% and -48463.96%.
Gross Margin 100% Operating Margin -33341.23% Pretax Margin -48183.44% Profit Margin -48463.96% EBITDA Margin -47186.04% EBIT Margin -33341.23% FCF Margin -26796.1%
